The disease usually occurs in domesticated, wild and caged birds which are susceptible. Furthermore, birds of all ages were found as susceptible to this disease 9 . Inhalation of aerosols is considered to be the primary mode of transmission of NDV within a flock 10 . Approximately two days after exposure and before showing any clinical signs, the infected birds begin to liberate virus in the air that leaves its respiratory tract and continues to do so for several days 11 . Coughing, gasping and disturbances of respiration are not required to generate an infective aerosol but probably enhances its production. Chickens infected with NDV have been used as a source of naturally generated aerosol particles to test efficacy of air filters in removing infections from air 12 . Coughing and sneezing may shed huge quantity of viruses and thus contaminate the chicken coop, equipment and clothing of personnel 13 . In Bangladesh, unexpected death of poultry causes economic loses of farmers and 30% of the mortality in poultry industry is caused by infectious diseases where ND virus plays an important role 14 . Newcastle disease, popularly known as Ranikhet disease in Bangladesh, considered as one of the most important threats to the poultry industry. ND claimed up to 40-60% of the total mortality in rural scavenging chickens in late seventies 15 . Routine vaccination is practiced in the country as a means of protection. Therefore, information about the types of vaccine, efficacy of the vaccine and vaccination schedules is very important issues when considered the protection of birds against ND. The types of vaccine and vaccination schedule adopted are influenced by a variety of factors such as, antigenicity of the vaccine given, virulence of the field virus, routes of vaccine administration and age of birds to be vaccinated 16 . Chittagong district is considered as one of the poultry belts in Bangladesh and thousand of poultry farms have established and poultry products from this area contribute as protein sources for the people of Bangladesh. In this study we selected two vaccines such as BCRDV1 (VG/GA strain) and BCRDV2 (F-strain). We selected both BCRDV1 and BCRDV2 based on availability and their low price. Considering the above mentioned factors, the study was undertaken to evaluate the performances of two commercial Newcastle disease vaccines in broiler birds reared under intensive system in Bangladesh.
The blood samples for this study were collected from three different commercial broiler farms and divided into three groups. The blood samples were stored in refrigerator for 2 to 3 hours in order to separate serum. After clotting of blood, serum was collected from each syringe in an Eppendorf tube (1.5ml capacity) and stored at -20 o C for further analysis in the laboratory of Microbiology of Chittagong Veterinary and Animal Sciences University. In case of protection test, birds in three groups were subsequently challenged with virulent field strain velogenic ND virus and result was observed properly. Field samples were preserved as a source of virulent strain of NDV in the Department of Microbiology, CVASU.
All birds were categorized into three different groups; group I marked as vaccinated with BCRDV1 (VG/GA strain), group II as vaccinated with BCRDV2 (F-strain) and group III as a control. Among these groups, samples were collected at the age of days 1, 7, 14, 21, 28 and 35 considering maximum 30 samples in each of three groups. The propagation of virus of the preserved samples was done on 9-10 days old chicken embryo in allantoic cavity. The allantoic fluid was collected and stored at -20 o C for analysis. The collected fluid was tested by micro plate Haemagglutination (HA) test for confirming the virulence properties of the virus by following standard method 17 .
Five milliliter of blood was collected in a tube containing anticoagulant from each chicken, which was vaccinated against ND and free from ND infection. After the blood sample was washed with an equal volume of phosphate-buffered saline (PBS) at pH 7.0. The supernatant was poured off, and 20 volume of PBS was added into the packed cells and washed twice. The cells were then used to prepare a 1% suspension based on volume by adding 1 ml of the packed cells to 100ml of PBS at pH 7.0.
Fifty microlitter of PBS dispended into each well of one row of the plastic V-bottomed 96 well plate. Then 50ml of virus suspension (Avinew® vaccine, Advance Animal Science Co. Ltd.) was placed into the first well and made two-fold dilutions. A row with control was also made using PBS only instead of virus antigen. This control well was made for showing the normal setting patterns and time of red blood cells in suspension. Then 50ml of PBS was added to each well (including control wells). Finally, 50ml of 1% chicken RBC suspension was added to each well, tilted gently and allowed to stand at room temperature for 45 minutes to stop dehydration. The results of the 8 th well were read and recorded to show haemagglutination (thin film) of 1 HA unit. Determination of 4HA unit virus antigen from this HA results was made as described by Ilaria and Alexander 18 .
Fifty microlitter of PBS was dispended into each well of first row of a plastic V-bottomed 96 well plate, and then 50ml of serum sample from test bird was placed into first well of the plate including control well. Two fold dilutions of 50ml volumes of serum were made across the plate and same volume of 4HA unit virus were added in each well except the control well. Then it was left for 30 minutes at room temperature (25 o C) and afterwards 50ml of 1% chicken RBC were added to each well including the control one. Following mixing them gently, plate was allowed to settle down for 40 minutes at room temperature. Finally, the result were read, and interpreted only to those wells in which the RBC streams at the same rate as the control wells. This finding was considered as showing inhibition. The validity of results was assessed against a negative control serum, which did not give a titre > log 2 4 . HI titre was regarded as being protective if there was inhibition at serum dilution of log 2 4 or more against 4HAU of the NDV used.
Thirty birds from each group were isolated and challenged subcutaneously on the day 35 th with a virulent field strain of NDV at a dose rate of 0.1 ml/ per bird. The birds were kept under close observation for 19 days to recognize the development of one set of clinical signs. Disease lesions were investigated and recorded through post-mortem examination and further, samples with lesions were used to isolate the virus. Total numbers of dead and live birds were also recorded. The preventable fraction/ protection index to evaluate the efficacy of vaccines was calculated using the previously described method by Tizard 19 . The level of antibody response was analyzed and compared between groups I and II by using a 2-sample t-test for equal variance as described by Steel and Torrie 20 . The value, P < 0.01 was considered as significant.
Level of maternally derived antibody (MDA) persists in the broiler birds were determined by haemagglutination inhibition (HI) test from day 1 to day 35. This study gives emphasis on the evaluation of the performances of two commercially available vaccines; BCRDV1 (VG/GA strain) and BCRDV2 (F strain) that were tested in broiler birds. The results of these tests stated as mean ± SD of HI titres of 30 broiler birds in each age groups (I, II, III) and measured at stages of pre-vaccination (day 1), post-primary (day 7 and 14) and post-secondary (day 21, 28 and 35) vaccination are presented in Table 1 .
It was observed that the mean ± SD of sera samples of groups I and II were 7.2±0.89 and 6.0±0.76 respectively on day 7 th whereas on day 14 th mean titres were 6.1±0.9 and 4.8±0.81 respectively. Similarly, it was found that on day 21; the mean ± SD of HI titres of group I and group II were 7.1± 0.75 and 5.8 ± 0.83 respectively. On the following occasion of day 28 and 35 the mean ± SD of HI titres in group I and II were 5.7 ± 0.72 and 4.9 ± 0.86; 4.1 ± 0.68 and 3.8 ± 0.77 respectively. After the challenge test vaccine gave 93.33% and 90% protection in group I and group II, respectively ( Table 2) . Unvaccinated (control) group was found highly susceptible to challenge as revealed by death of all birds. Birds that died following post-challenge test were examined by postmortem examination. Usually gross lesions were minimal in young or old birds although there were mild air sacculitis, tracheitis and conjunctivitis. The other changes observed were haemorrhagic or necrotic focal lesions in the mucosa of the intestine.
Study revealed that maternally derived antibody remained till the age of day 28 th but in minimal level, and then gradually disappeared and became completely absent after the age of day 28 th or onward. From our study it can be stated that the newly hatched chicks usually have a high level of maternal antibody declined to zero in chicks after the age of 25 days. However, in previous studies researchers reported that maternally derived antibody persist and remained protective until the age of 12 th days 15 , 17 th days 21 and 18 days 22 in chicks. The level of HI antibody titres exists during first two weeks of life [23] [24] . According to Islam et al. 25 , maternally derived antibody can be considered as an effective means of protection of the chickens till two weeks of age.
According to the findings of present study, the HI titres of group I showed fairly higher than group II those were vaccinated with BCRDV1 and BCRDV2 respectively, which is in line with the previous work done by Beard et al. 26 who stated VG/GA strain produced better immunity than B1. It is also similar to the findings of Mahmud 27 who stated that the mean HI titre was higher in birds vaccinated with Avinew® (VG/GA strain) than BCRDV (Fstrain). When we tested the protective ability of the host on the basis of post-challenge mortality at day 35, it was found that mortality to the challenges host is higher in group II (10%) than group I (6.67%). We treated the group III as a control (unvaccinated) and found that the level of HI titres gradually decreases day by day. Similarly, birds of control group showed 100% mortality and inference was made that the unvaccinated group fully susceptible to the disease, because the level of MDA was too low to protect the birds (unvaccinated) against ND. This finding highlighted that the birds vaccinated with BCRDV1 had 93.33% protection, although HI antibodies titers were low. It's also found that the minimum HI titre to resist challenge infection was 4 or even more 28 . Lower mortality in BCRDV1 vaccinated birds were also reported by Al-Garib et al. 29 . Vaccination is extensively used to protect birds against Newcastle disease (ND). During vaccination emphasis were given to some important factors for successful vaccination such as the efficacy of the vaccines used, types of vaccine available, route of administration, antigenicity of vaccine virus, age of birds and vaccination schedule etc. Vaccination is an effective control measure which relies on two aspects. Firstly, vaccination of the parent stock to ensure that the progeny chicks are hatched with a high level of maternally-derived antibody (MDA) and secondly, vaccination of the chickens with a suitable vaccine at the correct age. The resultant high level of MDA found in the progeny chickens is important in protecting the chicken during 10 to 14 days of age from NDV infection 30 .
From the above discussion it can be concluded that birds with BCRDV1 vaccine had more protective effects than BCRDV2. There is no remarkable difference found between the protective index of group I and group II, but significant differences was observed in the HI antibody titer between two groups. Therefore, BCRDV1 and BCRDV2 can be recommended for an effective ND control program under intensive conditions but BCRDV1 vaccine can be made much more preferable for protection of birds against Newcastle disease. The study suggests further investigation for more effective output about the performances of available BCRDV. 
Table1. Level of HI titre in birds vaccinated with ND vaccine of groups I, II and challenge test compared to unvaccinated group III.

